HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats.

AbstractAIM:
To determine whether ONO-1078 (pranlukast), a potent leukotriene receptor antagonist, has neuroprotective effect on focal cerebral ischemia in the rat.
METHODS:
Focal cerebral ischemia was induced by 30 min of middle cerebral artery (MCA) occlusion and followed by 24 h reperfusion. ONO-1078 (0.003-1.0 mg/kg) or vehicle (saline 1 mL/kg) was ip injected 30 min before MCA occlusion and 2 h after reperfusion. The neurological score, infarct volume, neuron density (in cortex, hippocampus, and striatum), brain edema, and albumin exudation around the vessels were determined 24 h after reperfusion.
RESULTS:
ONO-1078 slightly improved the neurological deficiency, and dramatically decreased infarct volume and neuron loss which showed a bell shaped dose response effect with highest effect at doses of 0.01-0.3 mg/kg. Enlargement of the ischemic hemisphere and albumin exudation were inhibited at doses of 0.01-1.0 mg/kg.
CONCLUSION:
ONO-1078 has the protective effect on focal cerebral ischemia in rats, which is partially attributed to the inhibition of brain edema. This may represent a novel approach to the treatment of acute cerebral ischemia with cysteinyl leukotriene receptor antagonists.
AuthorsWei-Ping Zhang, Er-Qing Wei, Ru-Huan Mei, Chao-Yang Zhu, Meng-Hui Zhao
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 23 Issue 10 Pg. 871-7 (Oct 2002) ISSN: 1671-4083 [Print] United States
PMID12370090 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chromones
  • Leukotriene Antagonists
  • Neuroprotective Agents
  • pranlukast
Topics
  • Animals
  • Blood-Brain Barrier (drug effects)
  • Brain Edema (prevention & control)
  • Chromones (pharmacology, therapeutic use)
  • Infarction, Middle Cerebral Artery (physiopathology)
  • Leukotriene Antagonists (pharmacology, therapeutic use)
  • Male
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: